Treatment of critical bleeding events in patients with immune thrombocytopenia : a protocol for a systematic review and meta-analysis
© 2023. The Author(s)..
BACKGROUND: Critical bleeding events in adults and children with ITP are medical emergencies; however, evidence-based treatment protocols are lacking. Due to the severe thrombocytopenia, (typically platelet count less than 20 × 109/L), a critical bleed portends a high risk of death or disability. We plan to perform a systematic review and meta-analysis of treatments for critical bleeding in patients with ITP that will inform evidence-based recommendations.
METHODS: Literature searches will be conducted in four electronic databases: Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and PubMed. Eligible studies will be randomized controlled trials or observational studies that enrolled patients with ITP describing one or more interventions for the management of critical bleeding. Title and abstract screening, full-text screening, data extraction, and risk of bias evaluation will be conducted independently and in duplicate using Covidence and Excel. Outcomes will be pooled for meta-analysis where appropriate or summarized descriptively. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology will be used to evaluate the certainty of the evidence. Primary outcomes of interest will include frequency of critical bleeds, mortality and bleeding-related mortality, bleeding resolution, platelet count, and disability.
DISCUSSION: Evidence-based treatments for critical bleeding in patients with ITP are needed to improve patient outcomes and standardize care in the emergency setting.
SYSTEMATIC REVIEW REGISTRATION: CRD42020161206.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Systematic reviews - 13(2024), 1 vom: 06. Jan., Seite 21 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sirotich, Emily [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Critical bleeding |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 25.03.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13643-023-02436-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366752367 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366752367 | ||
| 003 | DE-627 | ||
| 005 | 20240326235215.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13643-023-02436-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1348.xml |
| 035 | |a (DE-627)NLM366752367 | ||
| 035 | |a (NLM)38184622 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sirotich, Emily |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of critical bleeding events in patients with immune thrombocytopenia |b a protocol for a systematic review and meta-analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: Critical bleeding events in adults and children with ITP are medical emergencies; however, evidence-based treatment protocols are lacking. Due to the severe thrombocytopenia, (typically platelet count less than 20 × 109/L), a critical bleed portends a high risk of death or disability. We plan to perform a systematic review and meta-analysis of treatments for critical bleeding in patients with ITP that will inform evidence-based recommendations | ||
| 520 | |a METHODS: Literature searches will be conducted in four electronic databases: Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and PubMed. Eligible studies will be randomized controlled trials or observational studies that enrolled patients with ITP describing one or more interventions for the management of critical bleeding. Title and abstract screening, full-text screening, data extraction, and risk of bias evaluation will be conducted independently and in duplicate using Covidence and Excel. Outcomes will be pooled for meta-analysis where appropriate or summarized descriptively. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology will be used to evaluate the certainty of the evidence. Primary outcomes of interest will include frequency of critical bleeds, mortality and bleeding-related mortality, bleeding resolution, platelet count, and disability | ||
| 520 | |a DISCUSSION: Evidence-based treatments for critical bleeding in patients with ITP are needed to improve patient outcomes and standardize care in the emergency setting | ||
| 520 | |a SYSTEMATIC REVIEW REGISTRATION: CRD42020161206 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Critical bleeding | |
| 650 | 4 | |a Emergency management | |
| 650 | 4 | |a Immune thrombocytopenia | |
| 650 | 4 | |a Thrombocytopenia | |
| 700 | 1 | |a Nazaryan, Hasmik |e verfasserin |4 aut | |
| 700 | 1 | |a Chowdhury, Saifur Rahman |e verfasserin |4 aut | |
| 700 | 1 | |a Guyatt, Gordon |e verfasserin |4 aut | |
| 700 | 1 | |a Agarwal, Arnav |e verfasserin |4 aut | |
| 700 | 1 | |a Leong, Russell |e verfasserin |4 aut | |
| 700 | 1 | |a Wen, Aaron |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Bonnie |e verfasserin |4 aut | |
| 700 | 1 | |a Pallapothu, Sushmitha |e verfasserin |4 aut | |
| 700 | 1 | |a Rathod, Preksha |e verfasserin |4 aut | |
| 700 | 1 | |a Kwon, Henry Y |e verfasserin |4 aut | |
| 700 | 1 | |a Dookie, Jared |e verfasserin |4 aut | |
| 700 | 1 | |a Shafiee, Amirmohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Charness, Jay |e verfasserin |4 aut | |
| 700 | 1 | |a DiRaimo, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Paynter, Dale |e verfasserin |4 aut | |
| 700 | 1 | |a Pruitt, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Strachan, Gail |e verfasserin |4 aut | |
| 700 | 1 | |a Couban, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Zhikang |e verfasserin |4 aut | |
| 700 | 1 | |a Arnold, Donald M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Systematic reviews |d 2012 |g 13(2024), 1 vom: 06. Jan., Seite 21 |w (DE-627)NLM217806902 |x 2046-4053 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:1 |g day:06 |g month:01 |g pages:21 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13643-023-02436-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 1 |b 06 |c 01 |h 21 | ||